Authors
Latest:
Healthcare Reform and the Future of OncologyThe healthcare system in the United States has become increasingly unsustainable.
Latest:
Day in the Life of an Oncology FellowWhen my alarm goes off at 5:30 am, I wake up prepared to play many roles. Juggling family life with 2 young children, caring for my patients as a fellow, and pursuing scholarly activities leaves little free time.
Latest:
PrimeMD, a Pain Reporting Smartphone Application for Patients Undergoing Head and Neck RadiationA feasibility study of a smartphone application that patients undergoing radiation therapy for head and neck cancer can use to regularly report mucositis symptoms.
Latest:
Treatment Ends, but the Need for Care ContinuesCelebration at the end of cancer treatment is often premature.
Latest:
Dr Fleur-Lominy on Ongoing Research Within CML at the 2024 ASCO Annual MeetingShella Saint Fleur-Lominy, MD, PhD, and Yan Leyfman, MD, discuss ongoing research within the chronic myeloid leukemia patient population.
Latest:
The FDA Could Help Address Financial Toxicity During the Approval ProcessGiven the widespread financial impact the high cost of cancer drugs has on the healthcare system, it may be time for the FDA to take a broader approach when reviewing oncology drug applications. By also examining the cost of the drug, the FDA could shine a light on escalating drug costs and play a leadership role in creating new programs and initiatives that help patients pay for promising new therapies.
Latest:
Dr. Loi on the Association Between TILs and TrastuzumabSherene Loi, MD, PhD, on the association between immune cells and a pathologic complete response in patients with breast cancer after being given chemotherapy and trastuzumab.
Latest:
Sheri Holmen on Understanding Drivers of Melanoma MetastasisSheri Holmen, PhD, investigator, Associate Professor in the Department of Surgery, Adjunct Professor in the Department of Oncological Sciences, Huntsman Cancer Institute, the University of Utah School of Medicine, discusses understanding drivers for melanoma metastasis.
Latest:
Update on Vismodegib's Place in the Treatment of Advanced BCCBasal cell carcinoma (BCC) is the most common human malignancy and by far the most prevalent form of skin cancer, accounting for more than 80% of all cases.
Latest:
Dr. Jain on the Push Toward Personalized Treatment Approaches in CRC With Liver MetastasesShikha Jain, MD, FACP, discusses the push toward personalized treatment approaches in colorectal cancer with liver metastases.
Latest:
Key Takeaways on Evolving Bladder Cancer Treatment LandscapeThe expert panel concludes its discussion by providing key takeaways on the evolving bladder cancer treatment landscape following ESMO 2023.
Latest:
Geriatric Oncology: Learning the Balancing Act of Treating the Older Cancer PatientWhether it be to identify a seemingly frail older patient with metastatic colon cancer who would tolerate and benefit from standard treatment, or to prevent a frail older lung cancer patient from experiencing severe side effects due to adjuvant chemotherapy, oncologists are having to make difficult decisions with increasing frequency.
Latest:
Future Directions in ALK-Positive and BRAF-Positive NSCLC ManagementPanelists discuss how advancements in targeted therapies and personalized medicine are crucial for addressing the pressing unanswered questions in the management of ALK-positive and BRAF-positive cancers.
Latest:
Dr. Gadgeel on the Utility of Liquid Biopsies in Lung CancerShirish M. Gadgeel, MD, MBBS, Mary Lou Kennedy Research Professor in Thoracic Oncology, professor, Department of Internal Medicine, Division of Hematology/Oncology, co-leader, Thoracic Oncology Research Program, and associate director, Networking and Affiliated Centers, University of Michigan Medicine, discusses the utility of liquid biopsies in lung cancer.
Latest:
Evolution in the Field of HR+ Breast Cancer ManagementClosing out their discussion on HR+ breast cancer management, expert panelists share their excitement for the evolving treatment paradigm.
Latest:
5 Questions... with Cliff Chirls, President and COO of iMedExchangeClifford Chirls discusses the features of the new social networking site iMedExchange and explains how it diff ers from other social networking resources for physicians.
Latest:
Dr. Patel on Treatment Considerations in Advanced Squamous NSCLCShiven B. Patel, MD, MBA, FACP, discusses treatment considerations in patients with advanced squamous non–small cell lung cancer.
Latest:
Dr. Koyfman on Reirradiation Options for Head and Neck CancerShlomo Koyfman, MD, associate staff, radiation oncology, Cleveland Clinic, discusses reirradiation options for patients with head and neck cancer.
Latest:
Dr. Navai on Treatment Options in Relapsed/Refractory SarcomaShoba A. Navai, MD, an assistant professor, Department of Pediatrics, Section of Pediatric Hematology and Oncology, at Baylor College of Medicine, Texas Children’s Hospital, discusses treatment options for patients with relapsed/refractory sarcoma.
Latest:
Dr. Fukuoka on Dosage for Regorafenib/Nivolumab Combo in Gastric Cancer and CRCShota Fukuoka, MD, physician, National Cancer Center in Japan, discusses finding the recommended dosage of regorafenib plus nivolumab in patients with advanced gastric cancer or colorectal cancer.
Latest:
Dr Pant on the Importance of Targeted Therapy and Mutation Testing in Pancreatic CancerShubham Pant, MD, MBBS, discusses next-generation sequencing in pancreatic cancer, highlighting the importance of targeting RAS mutations when applicable.
